These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7603184)

  • 1. Current issues in management of thromboses.
    Clark S
    Lancet; 1995 Jul; 346(8967):113-4. PubMed ID: 7603184
    [No Abstract]   [Full Text] [Related]  

  • 2. Is thrombin a pharmacological target during reperfusion?
    White HD
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S55-7. PubMed ID: 10070820
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombin inhibitors in acute coronary artery disease.
    Vorchheimer DA; Fuster V
    Eur Heart J; 2002 Aug; 23(15):1142-4. PubMed ID: 12127916
    [No Abstract]   [Full Text] [Related]  

  • 4. Hirudin versus heparin and low-molecular-weight heparin: and the winner is..
    Hull RD; Pineo GF; Raskob GE
    J Lab Clin Med; 1998 Sep; 132(3):171-4. PubMed ID: 9735921
    [No Abstract]   [Full Text] [Related]  

  • 5. The comeback of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1991 Apr; 17(2):79-82. PubMed ID: 1771415
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant hirudin: a new prospect in thrombosis.
    Talbot M
    Curr Stud Hematol Blood Transfus; 1991; (58):1-7. PubMed ID: 1954755
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific thrombin inhibitors in vivo.
    Fitzgerald D
    Ann N Y Acad Sci; 1994 Apr; 714():41-52. PubMed ID: 8017791
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant and antithrombotic actions of recombinant hirudin.
    Kaiser B
    Semin Thromb Hemost; 1991 Apr; 17(2):130-6. PubMed ID: 1837615
    [No Abstract]   [Full Text] [Related]  

  • 9. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hirudin in disseminated intravascular coagulation.
    Nowak G; Markwardt F
    Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y; Inoue Y; Goto Y; Fukazawa T; Hayashi H
    Thromb Haemost; 1999 Feb; 81(2):250-5. PubMed ID: 10064001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of different hirudins and combinations of low doses of hirudin, heparin and acetylsalicylic acid in a rat microcirculatory thrombosis model.
    Krupinski K; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():88-92. PubMed ID: 1894199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct thrombin inhibitors (part 2 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Feb; 17(2):85-91. PubMed ID: 15687531
    [No Abstract]   [Full Text] [Related]  

  • 14. The direct thrombin inhibitor hirudin.
    Greinacher A; Warkentin TE
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leeches to hirulogs and other thrombin-directed antithrombotics.
    Fenton JW
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1121-9. PubMed ID: 1400076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hirudin and hirudin fragments].
    Deschamps A; Samama M
    Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):A49-53. PubMed ID: 1298182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of intra-coronary thrombosis in the anaesthetised dog: the importance of thromboxane A2 and thrombin.
    White BP; Sullivan AT; Lumley P
    Thromb Haemost; 1994 Mar; 71(3):366-74. PubMed ID: 8029802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of direct thrombin inhibitors in comparison with glycosaminoglycans.
    Markwardt F
    Semin Thromb Hemost; 2001 Oct; 27(5):523-30. PubMed ID: 11668423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1989 Jul; 15(3):269-82. PubMed ID: 2688099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.